Aprea Therapeutics Statistics

Total Valuation

APRE has a market cap or net worth of $9.85 million. The enterprise value is -$9.26 million.

Market Cap	9.85M
Enterprise Value	-9.26M

Important Dates

The last earnings date was Wednesday, May 14, 2025, before market open.

Earnings Date	May 14, 2025
Ex-Dividend Date	n/a

Share Statistics

APRE has 5.53 million shares outstanding. The number of shares has increased by 54.69% in one year.

Current Share Class	5.53M
Shares Outstanding	5.53M
Shares Change (YoY)	+54.69%
Shares Change (QoQ)	+0.66%
Owned by Insiders (%)	11.75%
Owned by Institutions (%)	15.63%
Float	3.48M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	8.40
Forward PS	n/a
PB Ratio	0.64
P/TBV Ratio	0.64
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 5.90

Current Ratio	5.90
Quick Ratio	5.73
Debt / Equity	n/a
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	n/a

Financial Efficiency

Return on equity (ROE) is -59.80% and return on invested capital (ROIC) is -40.49%.

Return on Equity (ROE)	-59.80%
Return on Assets (ROA)	-35.70%
Return on Invested Capital (ROIC)	-40.49%
Return on Capital Employed (ROCE)	-90.48%
Revenue Per Employee	$160,559
Profits Per Employee	-$1.76M
Employee Count	8
Asset Turnover	0.05
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -61.22% in the last 52 weeks. The beta is 1.61, so APRE's price volatility has been higher than the market average.

Beta (5Y)	1.61
52-Week Price Change	-61.22%
50-Day Moving Average	1.71
200-Day Moving Average	2.88
Relative Strength Index (RSI)	49.51
Average Volume (20 Days)	35,905

Short Selling Information

The latest short interest is 59,011, so 1.07% of the outstanding shares have been sold short.

Short Interest	59,011
Short Previous Month	59,980
Short % of Shares Out	1.07%
Short % of Float	1.69%
Short Ratio (days to cover)	2.63

Income Statement

In the last 12 months, APRE had revenue of $1.28 million and -$14.08 million in losses. Loss per share was -$2.36.

Revenue	1.28M
Gross Profit	-8.96M
Operating Income	-15.26M
Pretax Income	-12.72M
Net Income	-14.08M
EBITDA	-15.23M
EBIT	-15.26M
Loss Per Share	-$2.36

Full Income Statement

Balance Sheet

The company has $19.28 million in cash and n/a in debt, giving a net cash position of $19.28 million or $3.48 per share.

Cash & Cash Equivalents	19.28M
Total Debt	n/a
Net Cash	19.28M
Net Cash Per Share	$3.48
Equity (Book Value)	16.86M
Book Value Per Share	2.82
Working Capital	16.47M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -$13.25 million and capital expenditures -$7,500, giving a free cash flow of -$13.26 million.

Operating Cash Flow	-13.25M
Capital Expenditures	-7,500
Free Cash Flow	-13.26M
FCF Per Share	-$2.40

Full Cash Flow Statement

Margins

Gross Margin	n/a
Operating Margin	-1,187.69%
Pretax Margin	-1,096.27%
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

APRE does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-54.69%
Shareholder Yield	-54.69%
Earnings Yield	-140.65%
FCF Yield	-132.44%

Analyst Forecast

The average price target for APRE is $15.50, which is 770.79% higher than the current price. The consensus rating is "Strong Buy".

Price Target	$15.50
Price Target Difference	770.79%
Analyst Consensus	Strong Buy
Analyst Count	2
Revenue Growth Forecast (5Y)	139.71%
EPS Growth Forecast (5Y)	n/a

Stock Forecasts

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

The last stock split was on February 13, 2023. It was a reverse split with a ratio of 0.05:1.

Last Split Date	Feb 13, 2023
Split Type	Reverse
Split Ratio	0.05:1

Scores

APRE has an Altman Z-Score of -20.27 and a Piotroski F-Score of 3. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	-20.27
Piotroski F-Score	3